Windsor Financial Group’s Novartis NVS Stock Holding History

Windsor Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.87M	Sell	65,083 -2,604	-4%	-$185K	2.27%	20
2017 Q1	$4.5M	Sell	67,687 -1,339	-2%	-$89.2K	2.07%	25
2016 Q4	$4.5M	Buy	69,026 +1,398	+2%	+$90.7K	2.13%	22
2016 Q3	$4.79M	Sell	67,628 -3,392	-5%	-$247K	2.25%	19
2016 Q2	$5.25M	Buy	71,020 +3,346	+5%	+$231K	2.4%	14
2016 Q1	$4.39M	Buy	67,674 +5,532	+9%	+$376K	2.01%	22
2015 Q4	$4.79M	Buy	62,142 +5,755	+10%	+$457K	2.33%	13
2015 Q3	$4.64M	Sell	56,387 -222	-0.4%	-$19.8K	2.23%	19
2015 Q2	$4.99M	Sell	56,609 -1,566	-3%	-$144K	2.15%	17
2015 Q1	$5.14M	Sell	58,175 -1,803	-3%	-$160K	2.31%	13
2014 Q4	$4.98M	Sell	59,978 -1,061	-2%	-$87.9K	2.37%	12
2014 Q3	$5.15M	Sell	61,039 -783	-1%	-$63.4K	2.47%	12
2014 Q2	$5.01M	Sell	61,822 -1,423	-2%	-$112K	2.45%	12
2014 Q1	$4.82M	Sell	63,245 -725	-1%	-$52.8K	2.44%	10
2013 Q4	$4.61M	Sell	63,970 -502	-0.8%	-$34.9K	2.55%	9
2013 Q3	$4.43M	Sell	64,472 -586	-0.9%	-$38.8K	2.66%	4
2013 Q2	$4.12M	Buy	+65,058	New	+$4.23M	2.61%	6

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Windsor Financial Group's NVS Position: Q2 2017 in Review

Windsor Financial Group reduced its Novartis (NVS) stake by 3.8% in Q2 2017, selling an estimated $185K and leaving 65,083 shares worth $4.87M. The position accounts for 2.27% of the portfolio, ranked #20.

Windsor Financial Group first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $5.25M in Q2 2016. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Windsor Financial Group held 65,083 shares of Novartis worth $4.87M as of Q2 2017.
Windsor Financial Group sold 2,604 Novartis shares in Q2 2017, an estimated $185K.
Novartis made up 2.27% of Windsor Financial Group's portfolio in Q2 2017, its #20 holding.
Windsor Financial Group first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
Windsor Financial Group's Novartis position peaked at $5.25M in Q2 2016.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Windsor Financial Group's 13F filing for Q2 2017, filed 3 Aug 2017.